Back to search

United States· US:50484-010_155959d1-0367-4fb6-8877-29099d08801c

COLLAGENASE SANTYL

A collagenase clostridium histolyticum product containing collagenase clostridium histolyticum, registered in United States by SMITH & NEPHEW, INC. The same ATC class is registered in 5 of our 19 countries.

ATC M09AB02

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCOLLAGENASE SANTYLATCM09AB02REGISTER NO.US:50484-010_155959d1…PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Collagenase clostridium histolyticum is registered in 5 of 19 countries.

Countries holding a registration under ATC M09AB02 (collagenase clostridium histolyticum), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Collagenase clostridium histolyticum · ATC M09AB02

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
Manufacturer
SMITH & NEPHEW, INC
Country
United States (US)
ATC code
M09AB02
ATC class
Collagenase clostridium histolyticum
Defined daily dose
0.9 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    5048401030
    1 TUBE in 1 CARTON (50484-010-30) / 30 g in 1 TUBE
  • ndc11
    5048401090
    1 TUBE in 1 CARTON (50484-010-90) / 90 g in 1 TUBE
  • ndc11
    50484-010-30
  • ndc11
    50484-010-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

54 interactions on record for collagenase clostridium histolyticum.

Graded by severity as the source publishes them — 54 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Collagenase clostridium histolyticum · interactions on record

54 records

  • 54 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • HeparinB01AB01moderate
  • Antithrombin IIIB01AB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/018443d2-da62-4e56-a8ad-fc346cd069f7
GET /v1/drugs/018443d2-da62-4e56-a8ad-fc346cd069f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "250",
  "substance": "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM",
  "productndc": "50484-010",
  "dosage_form": "OINTMENT",
  "dea_schedule": null,
  "strength_unit": "[arb'U]/g",
  "application_number": "BLA101995",
  "marketing_category": "BLA"
}

See everything about collagenase clostridium histolyticum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.